Chagas disease etiology: Autoimmunity or parasite persistence?

Parasitology Today

Volumn 15, Issue 3, 1999, Pages

  Tarleton, Rick L ^a   Zhang, L ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; BENZNIDAZOLE; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; TRYPANOSOMA CRUZI VACCINE;

AUTOIMMUNITY; CHAGAS DISEASE; CYTOKINE PRODUCTION; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; POLYMERASE CHAIN REACTION; REVIEW; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

PROTOZOA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0033102525     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(99)01398-8     Document Type: Review

References (57)

1. Kalil J., Cunha-Neto E. Autoimmunity in Chagas disease cardiomyopathy: fulfilling the criteria at last? Parasitol. Today. 12:1996;396-399.
2. Cunha-Neto E.et al. Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. J. Clin. Invest. 98:1996;1709-1712.
3. Postan M., Dvorak J.A., McDaniel J.P. Studies of Trypanosoma cruzi clones in inbred mice I. A comparison of the course of infection of C3H/HEN-mice with two clones isolated from a common source. Am. J. Trop. Med. Hyg. 32:1983;497-506.
4. Monteon V.M.et al. American trypanosomosis: in situ and generalized features of parasitism and inflammation kinetics in a murine model. Exp. Parasitol. 83:1996;267-274.
5. Jones E.M.et al. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am. J. Trop. Med. Hyg. 48:1993;348-357.
6. Ben Younes-Chennoufi A.et al. Persistence of Trypanosoma cruzi antigens in the inflammatory lesions of chronically infected mice. Trans. R. Soc. Trop. Med. Hyg. 82:1988;77-83.
7. Higuchi M.d.L.et al. Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: light microscopy and immunohistochemical findings. Cardiovasc. Pathol. 2:1993;101-106.
8. Bellotti G.et al. In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease. Am. Heart J. 131:1996;301-307.
9. + in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. Clin. Immunol. Immunopathol. 83:1997;165-172.
10. Brandariz S.et al. Detection of parasite DNA in Chagas' heart disease. Lancet. 346:1995;1370-1371.
11. Vago A.R.et al. PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas' disease. Lancet. 348:1996;891-892.
12. Lane J.E.et al. Detection of Trypanosoma cruzi with the polymerase chain reaction and in situ hybridization in infected murine cardiac tissue. Am. J. Trop. Med. Hyg. 56:1997;588-595.
13. Vago A.R.et al. Kinetoplast DNA signatures of Trypanosoma cruzi strains obtained directly from infected tissues. Am. J. Pathol. 149:1996;2153-2159.
14. Olivares-Villagomez D.et al. Polymerase chain reaction amplification of three different Trypanosoma cruzi DNA sequences from human chagasic cardiac tissue. Am. J. Trop. Med. Hyg. 59:1998;563-570.
15. Tarleton R.L., Zhang L., Downs M.O. 'Autoimmune rejection' of neonatal heart transplants in experimental Chagas' disease is a parasite-specific response to infected host tissue. Proc. Natl. Acad. Sci. U. S. A. 94:1997;3932-3937.
16. Levin M.J. In chronic Chagas disease, don't forget the parasite. Parasitol. Today. 12:1996;415-416.
17. Kalil J., Cunha-Neto E. More on Chagas disease cardiomyopathy. Parasitol. Today. 13:1997;362-363.
18. Almeida D.R.et al. Chagas' disease reactivation after heart transplantation: efficacy of allopurinol treatment. J. Heart Lung Transplant. 15:1996;988-992.
19. Jardim E., Takayanagui O.M. Chagasic meningoencephalitis with detection of Trypanosoma cruzi in the cerebrospinal fluid of an immunodepressed patient. J. Trop. Med. Hyg. 97:1994;367-370.
20. Sartori A.et al. Simultaneous occurrence of acute myocarditis and reactivated Chagas' disease in a patient with AIDS. Clin. Infect. Dis. 21:1995;1297-1299.
21. Rocha A.et al. Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. Am. J. Trop. Med. Hyg. 50:1994;261-268.
22. Ferreira M.S.et al. Acute fatal Trypanosoma cruzi meningoencephalitis in a human immunodeficiency virus-positive hemophiliac patient. Am. J. Trop. Med. Hyg. 45:1991;723-727.
23. Silva J.S., Rossi M.A. Intensification of acute Trypanosoma cruzi myocarditis in BALB/c mice pretreated with low doses of cyclophosphamide or gamma irradiation. J. Exp. Pathol. 71:1990;33-39.
24. Okumura M.et al. Effects of immunosuppression and benzonidazole on Trypanosoma cruzi parasitism during experimental acute Chagas' disease. Transplant. Proc. 26:1994;1587-1589.
25. Boullon F.et al. Experimental cardiac transplantation and chronic Chagas' disease in dogs. Transplant. Proc. 20:1988;432-437.
26. Andrade Z.A., Andrade S.G., Sadigursky M. Enhancement of chronic Trypanosoma cruzi myocarditis in dogs treated with low doses of cyclophosphamide. Am. J. Pathol. 127:1987;467-473.
27. Tarleton R.L.et al. Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infect. Immun. 62:1994;1820-1829.
28. Tarleton R.L.et al. Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int. Immunol. 8:1996;13-22.
29. Minoprio P.et al. Xid-associated resistance to experimental Chagas' disease is IFN-gamma dependent. J. Immunol. 151:1993;4200-4208.
30. El Cheikh M.C.et al. CD5 B cells. Potential role in the (auto)immune responses to Trypanosoma cruzi infection. Ann. New York Acad. Sci. 651:1992;557-563.
31. + T lymphocytes in the inflammatory lesions of mice with acute Trypanosoma cruzi infection. Am. J. Trop. Med. Hyg. 48:1993;161-169.
32. Zhang L., Tarleton R.L. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. Eur. J. Immunol. 26:1996;102-109.
33. Higuchi M.d.L.et al. Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Arch. A. Pathol. Anat. Histopathol. 423:1993;157-160.
34. + T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. Am. J. Trop. Med. Hyg. 56:1997;485-489.
35. Kaplan M.H.et al. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity. 4:1996;313-319.
36. Samudio M.et al. Differential expression of systemic cytokine profiles in Chagas' disease is associated with endemicity of Trypanosoma cruzi infections. Acta Trop. 68:1998;89-97.
37. Viotti R.et al. Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am. Heart J. 127:1994;151-162.
38. Andrade A.L.et al. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet. 348:1996;1407-1413.
39. Andrade S.G.et al. Reversibility of cardiac fibrosis in mice chronically infected with Trypanosoma cruzi, under specific chemotherapy. Mem. Inst. Oswaldo Cruz. 86:1991;187-200.
40. Andrade S.G.et al. Specific chemotherapy of Chagas disease: a comparison between the response in patients and experimental animals inoculated with the same strains. Trans. R. Soc. Trop. Med. Hyg. 86:1992;624-626.
41. de Andrade A.L.et al. Early electrocardiographic abnormalities in Trypanosoma cruzi - seropositive children. Am. J. Trop. Med. Hyg. 59:1998;530-534.
42. Higuchi M.L.et al. The role of active myocarditis in the development of heart failure in chronic Chagas' disease: a study based on endomyocardial biopsies. Clin. Cardiol. 10:1987;665-670.
43. Palacios-Pru E.et al. Ultrastructural characteristics of different stages of human chagasic myocarditis. Am. J. Trop. Med. Hyg. 41:1989;29-40.
44. Lima M.T., Lenzi H.L., Gattass C.R. Negative tissue parasitism in mice injected with a noninfective clone of Trypanosoma cruzi. Parasitol. Res. 81:1995;6-12.
45. Rowland E.C., Levy R.L. Cardiac histology of mice with experimental Chagas' disease. J. Parasitol. 73:1987;240-241.
46. Mirkin G.A.et al. Experimental Chagas' disease: electrophysiology and cell composition of the neuromyopathic inflammatory lesions in mice infected with a myotropic and a pantropic strain of Trypanosoma cruzi. Clin. Immunol. Immunopathol. 73:1994;69-79.
47. Said G.et al. Neuropathy associated with experimental Chagas' disease. Ann. Neurol. 18:1985;676-683.
48. + T cells able to mediate parasite-specific delayed-type hypersensitivity play a role in the pathology of experimental Chagas' disease. Eur. J. Immunol. 17:1987;1027-1033.
49. Mirkin G.A.et al. Different Trypanosoma cruzi strains promote neuromyopathic damage mediated by distinct T lymphocyte subsets. Clin. Exp. Immunol. 107:1997;328-334.
50. Silva-Barbosa S.D.et al. Involvement of laminin and its receptor in abrogation of heart graft rejection by autoreactive T cells from Trypanosoma cruzi-infected mice. J. Immunol. 159:1997;997-1003.
51. Ribeiro-dos-Santos R.et al. Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi. J. Exp. Med. 175:1992;29-39.
52. Hemmer B.et al. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J. Exp. Med. 185:1997;1651-1659.
53. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:1994;991-1045.
54. Barnaba V., Sinigaglia F. Molecular mimicry and T cell-mediated autoimmune disease. J. Exp. Med. 185:1997;1529-1531.
55. DosReis G.A. Cell-mediated immunity in experimental Trypanosoma cruzi infection. Parasitol. Today. 13:1997;335-342.
56. McKerrow J.H., McGrath M.E., Engel J.C. The cysteine protease of Trypanosoma cruzi as a model for antiparasite drug design. Parasitol. Today. 11:1995;279-282.
57. Wizel B., Garg N., Tarleton R.L. Vaccination with trypomastigote surface antigen-1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection. Infect. Immun. 66:1998;5073-5081.